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The aim: The creation of a mathematical model of survival in patients with colon adenocarcinoma based on multivariable analysis of the 
state of cancer cell nuclear apparatus. Patients and Methods: The study was performed on 141 samples of biopsy materials or material 
obtained during surgical treatment of the patients with colon adenocarcinoma or benign colon neoplasms with the use of histological, 
morphometric, densitometric, immunohistochemical and mathematical methods. Results: It has been shown that each discrete pattern 
of the state of adenocarcinoma cell nuclei (quantity of DNA, the number and volume of nuclear organizer regions, expression rates 
of Ki-67, Bcl-2 and p53) is prognostically invalid in the case of its separate use. Combination of these characteristics significantly en-
hances prognostic validity of the survival model. Based on equation of Cox proportional hazards, survival model of good quality for the 
patients with moderately and poorly differentiated adenocarcinoma and increased average DNA content in tumor cell nuclei has been 
created. Conclusion: The proposed survival model for colon adenocarcinoma demonstrates the quality twice superior to the model based 
on the use of tumor grade only (G) which in fact is presently used as a sole common independent histological criterion of prognosis.
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Convenient systems for evaluation based on diffe­
rentiation grade of colon adenocarcinoma (АС) some­
times are not optimal due to the difficulties of objective 
assessment and prognostic validity required for a choice 
of correct treatment of AC patients [1, 2]. Therefore, the 
search for new criteria and the development of prognos­
tic means is of importance for clinicians [3–6].
In the process of neoplastic transformation nuclear 
apparatus undergoes significant changes caused 
by genome damage and its altered replication during 
cell division and realization of genetic information. 
In particular, structural organization and size of nuclei, 
state of nucleolar organizer regions, DNA quantity 
(polyploidy and aneuploidy), immunohistochemical 
markers of proliferation and apoptosis regulation, and 
a great variety of other features, have been studied. 
On large cohorts of AC patients there has been shown 
a relation of some patterns of the state of tumor cell 
nuclei with the properties of neoplasms and prognosis. 
However, when these schemes have been applied for 
prognosis in an individual patient, they were found 
to be of low significance with large error range. There­
fore, discrete patterns could be considered as such 
which use for prognosis is of limited accuracy.
Some patterns of nuclear state are directly or indirect­
ly interrelated, in particular, mitotic activity, DNA quantity 
(synthesis, ploidy, aneuploidy), the state of nuclear or­
ganizer regions (NOR), apoptosis regulation. Increased 
and uncontrolled mitotic activity is among the main fea­
tures of tumor growth. This could be accompanied with 
malfunction of mitosis mechanisms (upon chromosomal 
instability) leading to the development of polyploidy 
or aneuploidy. Along with this, DNA synthesis prece­
ding division, at conditions of high proliferation activity 
results also in a certain increase of total DNA quantity 
in tumor cells. From other side, lesion of mechanisms 
of apoptosis and survival of the cells, especially the cells 
with increased content of DNA in nuclei, also promotes 
an elevation of medium DNA content in tumor cell nuclei.
The aim of the work: the creation of a mathemati­
cal model of survival in patients with colon AC based 
on multivariable analysis of the state of cancer cell 
nuclear apparatus.
PATIENTS AND METHODS
The study was performed on 141 samples of  biopsy 
materials or materials obtained during surgical treat­
ment of the patients with colon AC or benign colon neo­
plasms: conventionally normal colon tissue (C; n = 11); 
polyps and adenomas (В; n = 16); AC of different 
grades: G1 (n = 28); G2 (n = 73); G3 (n = 13).
The material was fixed in a buffered 10% formaline 
(pH 7.4, 4 °С, 24 h) and embedded in paraplast with the 
use of Histos­5 histoprocessor (Milestone, Italy). From 
paraffin blocks, 5 µm sections were cut using Microm 
НМ325 (Thermo Scientific, Germany). The sections 
were stained with hematoxylin and eosin for common 
tumor assessment, or with Einarson’s gallocyanin 
chrome alum stain (pH 1.62, 37 °С, 24 h) for determi­
nation of nucleic acid content [7]. In each case, a part 
of sections was treated with RNAase (Macherey­Nagel 
GmbH & Co. KG, Germany) for RNA destruction [8]. 
NOR were detected using silver nitrate impregnation. 
Immunohistochemical reactions were performed with 
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the use of mouse monoclonal antibodies against anti­
gen Ki­67 (MIB­1, Dako, Denmark), Bcl­2 oncoprotein 
(Dako, Denmark), and р53 protein (Dako, Denmark) 
according to the instructions of the manufacturer and vi­
sualized using detection system EnVisionTM FLEX (Dako, 
Denmark). The sections were additionally stained with 
Gill hematoxylin.
The preparations were examined and photographed 
using microscope Nikon Eclipse 80i supplied with 
ca mera DS­5SMc/L2 at standardized conditions, im­
ages (× 400, 1280 × 960 pixels RGB) were processed 
using analysis system ImageJ 1.46. In images of the 
preparations stained with gallocyanin chrome alums, 
in each 30 tumor cells there have been determined 
cross­sectional area of cell nucleus, medium (DM) 
and integral optical density of nucleus, and the quantity 
of nuclear DNA (NDNA). For calculation of the latest 
index, DNA content in lymphocyte nuclei was accepted 
as a unit (c.u.) [9]. The tumors were distributed into 
three ranks by average DNA content: D — average DNA 
content up to 1.2 c.u., D+ — average DNA content from 
1.2 to 2.5 c.u., T+ — average DNA content higher than 
2.5 c.u. [10]. In silver­impregnated sections, in each 
50 tumor cells there was determined cross­sectional 
area of nucleus, quantity of NOR in nucleus (nNOR), and 
diameter of each NOR with following calculation of their 
total volume (vNOR). In each tumor, the percent of cells 
expressing Ki­67, Bcl­2, and р53 has been determined.
Statistical analysis was performed with the use of IBM 
SPSS Statistics 22. For assessment of normality, one 
sample Kolmogorov — Smirnov test was used. Cor­
relation analysis was performed using Spearman rank 
correlation method. The differences between the groups 
were evaluated by Mann — Whitney U test. Survival analy­
sis was performed by Kaplan — Meier estimator using 
log­rank test for evaluation of the differences between 
the groups.
For creation of survival models, Cox proportional 
hazards model (Cox regression model) was used. 
Standard form of regression equation is:
S(t) = S0(t)e(β1x1 + ... + βixi),
where: S(t) — survival at time t; S0(t) — baseline 
survival; βi — regression parameters; xi — the studied 
characteristics of tumor cell nuclear apparatus: X1 — 
0 if AC differentiation grade is G2, 1 — if AC differen­
tiation grade is G3; X2 — ratio of nNOR/Ki­67 values; 
X3 — product of nNOR × NDNA values; X4 — derivative 
of nNOR × NDNA/Ki­67; X5 — DNA content rank, may 
be of three values (D, D+ or T+); X6 — 0 corresponds 
to rank D+, 1 — to rank T+.
To build the models of prognosis on the basis of Cox 
regression, different number of nuclear apparatus 
features were used.
Model I includes just a single characteristic X1.
Model II includes X2, X3, and X4 (three characteristics).
Model III includes all 4 characteristics of mo­
dels I and II.
Model IV includes 5 characteristics: X1, X2, X3, X4, 
and X5.
Model V also includes 5 characteristics: X1,X2, X3, X4, X6.
The prognostic validity of the developed models 
was compared with that of basic Cox model that 
doesn’t include any characteristics of tumor process 
with the use of likelihood ratio test (LR). As an index 
of prognosis model quality (survival of patients) 
there has been used ROC­analysis where area under 
the curve (AUC) reflects model quality as follows: 
0.5–0.6 — bad, 0.6–0.7 — fair, 0.7–0.8 — good, 
0.8–0.9 — very good, 0.9–1.0 — perfect. The diffe­
rences were considered significant if p < 0.05.
RESULTS AND DISCUSSION
The performed study has shown that average DNA 
content in cell nuclei of tumors of different grade vari­
ed from 2.06 (G3) to 2.38 (G1) (Table 1). While the 
differences between groups C and B were significant 
(р < 0.05), the differences between various G were 
insignificant (р > 0.05). In the studied sample among 
AC of different grades (В, G1, G2, G3) there were the 
tumors with different DNA content ranks (D, D+, T+). 
Table 1. Quantitative values of features of nuclear apparatus of tumor cells of colon AC and benign colon neoplasms
Feature
Conventionally normal 
colon tissue Benign colon neoplasms
Colon AC
G1 G2 G3
M m M m M m M m M m
NDNA, cu 1.32 0.07 2.22* 0.31 2.38 0.20 2.06 0.09 2.06 0.16
nNOR, n 1.70 0.07 3.02** 0.13 2.90 0.16 2.39** 0.09 2.25 0.19
D 1.87 0.03 2.77 0.05 2.85 0.19 2.19 0.31
D+ 1.66 0.08 2.74** 0.15 3.09 0.32 2.46* 0.11 2.36 0.22
T+ 3.47 0.21 2.73* 0.23 2.30 0.22 2.01 0.38
vNOR, mkm3 1.96 0.08 2.80** 0.18 2.65 0.19 2.86 0.14 3.25 0.43
D 1.93 0.01 2.58 0.20 2.51 0.13 2.45 0.45
D+ 1.97 0.10 2.56* 0.21 2.70 0.35 2.89 0.15 2.86 0.42
T+ 3.18 0.36 2.66 0.29 2.98 0.36 4.14 1.00
Ki-67, % 6.16 3.79 34.56* 6.37 36.59 5.00 46.07 3.22 49.09 8.50
D 15.96 7.45 41.14 6.61 54.80 9.94
D+ 37.66* 8.47 27.43 7.01 46.81* 4.05 50.58 9.39
T+ 37.16 12.36 44.52 9.42 39.44 6.16 45.75 20.12
Bcl-2, % 28.95 3.87 33.88** 10.26 41.23 8.27 40.73 5.28 17.60 7.48
D 44.00 22.48 30.80 19.45 44.42 15.98
D+ 39.71 18.93 32.63 12.31 40.96 6.56 24.15 10.16
T+ 22.00 13.92 55.36 13.65 37.82 11.32 2.85 1.77
p53, % 6.28 3.54 14.95** 7.60 50.50** 7.52 65.70* 4.59 37.43* 10.21
D 12.40 12.40 50.00 20.86 54.46 14.03
D+ 0 0 41.98* 11.12 63.34* 5.90 38.83 12.29
T+ 33.67 17.55 60.01 12.01 80.16 7.03 34.27* 21.03
Note: NDNA — content of DNA in nucleus (cu); D, D+, T+ – DNA content ranks; nNОR — number of nucleolar organizers; vNОR — total volume of nucleolar 
organizers; Ki-67, Bcl-2, p53 — expression level of corresponding marker in tumor; p — significance: *p < 0.05, **p < 0.01 (comparing with previous group).
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If one takes into account the variability of this index, its 
use as a criterion of tumor grading and independent 
prognostic factor seems to be improper [9, 11]. Also, 
the decrease of DNA content ranks in nuclei of tumor 
cells along with G increase in combination with re­
striction of cellular heterogeneity via reduction on the 
number of hyperploid cells [9], supports the realiza­
tion of clonal evolution during AC progression [8, 12].
Number of NОR in tumor cell nuclei tended to de­
crease along with increase of grade while their total 
volume (vNОR) has been increasing; however, the 
differences between these indexes in approximal 
tumor groups were insignificant. Therein, the direct 
dependence between nNОR/vNОR was not found. 
An absence of proportional increase of nNОR/vNОR 
in tumor cell nuclei along with elevation of DNA content 
is evidence of DNA dysfunction or inactivity [9]. This 
phenomenon could be considered as a manifestation 
of decreased viability of these cells leading to ageing, 
apoptosis, and elimination of such morphofunctional 
types from a tumor [13, 14].
All studied tumors have shown Ki­67 expression in­
dex higher than zero, which ranged from 2.17% to prac­
tically 100% with a median of 37%. In general, there was 
recorded a sharp rise of tumor cell Ki­67 expression 
index in group B vs. C with its following moderate in­
crease. Observed tumors have wide range of Bcl­2 and 
p53 expression. The correlation between G and DNA 
content in nucleus of tumor cell was noticed.
The performed correlation analysis has shown 
that there are a number of statistically significant 
weak relations between the parameters. G correlated 
with nNОR (r = −0.340; p < 0.01) and their average 
volume (r = −0.348; p < 0.01), but had no correla­
tion with vNОR. Apart from this, there was recorded 
a relation between increase of Ki­67 labeling index 
and tumor grade (r = 0.193; p < 0.05), and also with 
nNОR (r = −0.202; p < 0.05). Positive correlation was 
determined also for p53 and G (r = 0.227; p < 0.05).
Survival analysis dependent on discrete patterns 
has shown that it significantly differed only in the 
groups distributed only by grade (G) (p < 0.01). No sta­
tistically significant differences between Bcl­2(+/−) 
and p53(+/−) groups has been revealed (Table 2). 
However, in the tumors with different DNA content 
ranks there has been observed a tendency for survival 
change. It was the highest in rank D and the lowest 
in rank T+. This fact could be explained by the different 
mechanisms of development of these neoplasms [15]. 
Tumors from rank D may be refer to ones which de­
velop via epigenetic mechanisms and microsatellite, 
while ranks D+ and T+ — chromosome instability.
The data obtained in correlation analysis and sur­
vival analysis in the groups allowed to build a survival 
model using Cox regression (proportional hazards 
model). Initially the models have been created and 
there was performed an analysis by the method of di­
rect inclusion of large factor array for their assessment 
as prognostic criteria for all sampling, including benign 
neoplasms as well (Table 3). The data of regression 
analysis (Cox regression model) have demonstrated 
that the use of factors which characterize the state 
of tumor cell nuclei discretely or independently of each 
other, did not allow to build a significant model. This 
is related to insignificant (p > 0.05) influence of these 
factors on survival, and their impact did not alter sig­
nificantly regression equation.
Table 2. Comparing of patients survival with colon AC in different groups 
using log-rank test (null hypothesis — there is no difference between 
groups)
Distribution of tumors into subgroups by the patterns χ2 p
G (B, G1, G2, G3) 42.617 <0.01
Quantity of DNA (D, D+, T+) 1.638 0.441
Bcl-2+ and Bcl-2− 0.054 0.816
p53+ and p53− 0.116 0.733
Ki-67 (distribution relative to median (37%)) 0.275 0.600
nNOR (distribution relative to median (2.57)) 0.181 0.671
Note: G — tumor grade; D, D+, T+ — DNA content ranks; Bcl-2 — Bcl-2 ex-
pression in tumor; p53 — expression in tumor.
Table 3. Prognostic significance of discrete features of nuclear apparatus 
of tumor cells (Cox model)
Feature β SE p
Tumor grade (G) 2.097 0.432 < 0.01
vNOR 0.128 0.202 0.526
Ki-67, % 0.001 0.009 0.897
Bcl-2, % 0.002 0.006 0.731
p53, % 0 0.006 0.98
NDNA 0.103 0.248 0.678
nNOR 0.065 0.278 0.814
D, D+, T+ 0.452 0.375 0.228
Note: β — coefficient; SE — standard error of coefficient; p — significance; 
nNOR — number of nucleolar organizers; vNOR — total volume of nucleolar or-
ganizers; Ki-67, Bcl-2, p53 — expression level of corresponding marker in tu-
mor; NDNA — quantity of DNA cu in nucleus; DM — medium optical density 
of nucleus; G — tumor grade; D, D+, T+ — DNA content ranks.
As far as tumor grading (G) is the only one sig­
nificant prognostic criterion, it has been used in the 
following analysis as a base for model building. Apart 
from this, to elevate model accuracy groups B and 
G1 were excluded because in these groups there has 
been recorded 100% 5­year survival rate, what pre­
conditions their uninformativeness.
For assessment of prognostic validity of a combi­
nation of the factors, we have performed a number 
of procedures of direct and inverse inclusion of the 
variables in regression model. There have been used 
either discrete factors or their combinations and their 
interrelation has been analyzed (Table 4).
Inclusion of two tumor grading values — G2 and 
G3 into regression equation produced a significant 
model (Model І), but with low AUC (0.339) (Figure). 
However, positive value β = 1.87 indicates that the 
higher G increases the likelihood of lethal outcome.
The search for significant combination of factors 
allowed to include such elements as NDNA, nNOR and 
Ki­67 which formed a base for Model ІІ. Its analysis has 
shown that simultaneous increase of NDNA and nNOR 
increases the risk of death. However, increase of nNOR 
in parallel with the decrease of Ki­67 expression index 
elevates the risk. The quality of this model is practically 
equal from the first one what indicates their similarly 
low prognostic validity (see Table 4).
Joining of Models I and II into a new Model ІІІ has been 
found to be rational because it resulted in a decrease 
of LR and an increase of AUC up to 0.605 (see Figure), 
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what however couldn’t be considered statistically sig­
nificant at p = 0.18. Better result was obtained after 
inclusion of feature of DNA content ranks (D, D+, T+) into 
regression equation. This procedure led to the model 
of better quality (Model IV): AUC = 0.663 (see Table 4). 
Further, the best model was obtained using D+ and 
T+ ranks (Model V), AUC = 0.722 — fair quality. Thus, 
Model V based on 5 features: X1, X2, X3, X4, X6, acquired 
the best properties of quality and informativeness among 
other models.
Table 4. Regression parameters and features included to the model upon 
regression analysis of survival (Cox model) of AC patients
Model n LR p (LR) AUC p (AUC)
Para me-
ter/s β SE p (β)
І 74 10.42 <0.01 0.339 0.05 X1 1.870 0.504 <0.01
ІІ 74 8.95 0.03 0.391 0.18 X2 0.159 0.063 0.01
X3 0.239 0.080 <0.01
X4 −0.069 0.028 0.01
ІІІ 74 20.67 <0.01 0.605 0.18 X1 2.031 0.517 <0.01
X2 0.173 0.066 <0.01
X3 0.265 0.086 <0.01
X4 −0.074 0.028 0.01
IV 74 25.44 <0.01 0.663 0.04 X1 1.932 0.531 <0.01
X2 0.279 0.087 <0.01
X3 0.211 0.094 0.03
X4 −0.118 0.038 <0.01
X5 1.459 0.692 0.04
V 65 28.14 <0.01 0.722 <0.01 X1 1.936 0.557 <0.01
X2 0.378 0.107 <0.01
X3 0.232 0.104 0.03
X4 −0.159 0.049 <0.01
X6 2.006 0.801 0.01
Note: n — number of cases included into analysis; LR — likelihood ratio 
(comparing with null model); AUC — area under ROC curve; β — coefficient; 
SE — standard error of coefficient; p () — significance for LR, AUC and β; 
X1 — tumor grade (G2 or G3); X2 = nNOR/Ki-67; X3 = nNOR × NDNA; X4 = 
nNOR × NDNA/Ki-67; X5 — DNA content ranks (D, D+ or T+); X6 — DNA con-
tent ranks (D+ or T+).
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Figure. ROС­analysis of different survival models in colon 
AC. I–V — ROС curves for different models
S0(t) value is calculated on the basis of sampling 
by Cox regression with the use of SPSS program for 
different t values (Table 5). Using the baseline function 
values at time t, and the values of equation variables 
(nNOR, Ki­67, NDNA, G) obtained by their direct 
measurement in an individual patient, and introducing 
them into formula 1 accounting the values of the coef­
ficients, the values of survival function for the patient 
S(t) for different t could be calculated (see Table 5).
So, the performed studies have shown that discrete 
patterns of AC cell nuclei state (DNA quantity, number 
and volume of NOR, expression rates of Ki­67, Bcl­2 and 
p53) are prognostically invalid in a case of their separate 
use and could not be considered as direct prognostic 
criteria. However, the derivatives of a number of pat­
terns could serve as significant criteria for prognosis 
(in particular, nNOR/Ki­67, nNOR × NDNA, and nNOR × 
NDNA/Ki­67). Besides, upon their use in survival model 
mathematically expressed dependence is not linear and 
is described by more complex functions (in this case, 
exponential one). Good quality survival model based 
on Cox proportional hazards model for patients with 
АС of G2 and G3, with increased DNA content in tumor 
cell nuclei, has been created.
Table 5. Estimated survival function for patients with colon AC (Model V) 
for mean values of features
t 3 5 7 8 9 10 11 36
S0(t) 1.000 0.998 0.996 0.994 0.993 0.992 0.985 0.980
S(t) 0.996 0.982 0.968 0.951 0.941 0.931 0.876 0.836
Note: t — survival time, months; S0(t) — baseline survival at time t; S(t) — sur-
vival function at time t.
The proposed survival model in the case of AC de­
monstrates the quality twice superior to that of a model 
based just on the use of tumor grade (G), which pre­
sently is a single common independent histological 
criterion of prognosis [3, 2].
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